Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Consolidated Net Income (2020 - 2025)

Historic Consolidated Net Income for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to -$5.5 million.

  • Cytek Biosciences' Consolidated Net Income fell 67147.34% to -$5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.8 million, marking a year-over-year decrease of 2623.35%. This contributed to the annual value of -$6.0 million for FY2024, which is 5044.45% up from last year.
  • Per Cytek Biosciences' latest filing, its Consolidated Net Income stood at -$5.5 million for Q3 2025, which was down 67147.34% from -$5.6 million recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Consolidated Net Income registered a high of $9.6 million during Q4 2024, and its lowest value of -$11.4 million during Q1 2025.
  • Its 5-year average for Consolidated Net Income is -$1.9 million, with a median of -$1.2 million in 2021.
  • Over the last 5 years, Cytek Biosciences' Consolidated Net Income had its largest YoY gain of 41914.16% in 2022, and its largest YoY loss of 221568.63% in 2022.
  • Quarter analysis of 5 years shows Cytek Biosciences' Consolidated Net Income stood at -$1.2 million in 2021, then surged by 419.14% to $3.7 million in 2022, then soared by 47.18% to $5.5 million in 2023, then soared by 75.49% to $9.6 million in 2024, then tumbled by 156.95% to -$5.5 million in 2025.
  • Its Consolidated Net Income was -$5.5 million in Q3 2025, compared to -$5.6 million in Q2 2025 and -$11.4 million in Q1 2025.